These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 29431121

  • 1. Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism.
    Municio C, Dominguez-Soto Á, Fuentelsaz-Romero S, Lamana A, Montes N, Cuevas VD, Campos RG, Pablos JL, González-Álvaro I, Puig-Kröger A.
    Ann Rheum Dis; 2018 May; 77(5):752-759. PubMed ID: 29431121
    [Abstract] [Full Text] [Related]

  • 2. Methotrexate selectively targets human proinflammatory macrophages through a thymidylate synthase/p53 axis.
    Municio C, Soler Palacios B, Estrada-Capetillo L, Benguria A, Dopazo A, García-Lorenzo E, Fernández-Arroyo S, Joven J, Miranda-Carús ME, González-Álvaro I, Puig-Kröger A.
    Ann Rheum Dis; 2016 Dec; 75(12):2157-2165. PubMed ID: 26920997
    [Abstract] [Full Text] [Related]

  • 3. Methotrexate promotes the release of granulocyte-macrophage colony-stimulating factor from rheumatoid arthritis fibroblast-like synoviocytes via autocrine interleukin-1 signaling.
    Bergström B, Selldén T, Bollmann M, Svensson MND, Ekwall AH.
    Arthritis Res Ther; 2024 Oct 11; 26(1):178. PubMed ID: 39394168
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
    Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N, Akashi S, Miyake K, Godowski PJ, Makino H.
    Arthritis Rheum; 2004 May 11; 50(5):1457-67. PubMed ID: 15146415
    [Abstract] [Full Text] [Related]

  • 6. TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype.
    Quero L, Hanser E, Manigold T, Tiaden AN, Kyburz D.
    Arthritis Res Ther; 2017 Nov 02; 19(1):245. PubMed ID: 29096690
    [Abstract] [Full Text] [Related]

  • 7. Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate.
    Varani K, Massara A, Vincenzi F, Tosi A, Padovan M, Trotta F, Borea PA.
    Arthritis Rheum; 2009 Oct 02; 60(10):2880-91. PubMed ID: 19790066
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Honokiol possesses potential anti-inflammatory effects on rheumatoid arthritis and GM-CSF can be a target for its treatment.
    Wang XD, Wang YL, Gao WF.
    Int J Clin Exp Pathol; 2015 Oct 02; 8(7):7929-36. PubMed ID: 26339358
    [Abstract] [Full Text] [Related]

  • 10. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets.
    Liu W, Zhang Y, Zhu W, Ma C, Ruan J, Long H, Wang Y.
    Front Immunol; 2018 Oct 02; 9():2228. PubMed ID: 30319663
    [Abstract] [Full Text] [Related]

  • 11. Tumor necrosis factor-alpha promotes survival in methotrexate-exposed macrophages by an NF-kappaB-dependent pathway.
    Lo SZ, Steer JH, Joyce DA.
    Arthritis Res Ther; 2011 Feb 15; 13(1):R24. PubMed ID: 21324111
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
    Dai SM, Matsuno H, Nakamura H, Nishioka K, Yudoh K.
    Arthritis Rheum; 2004 Feb 15; 50(2):432-43. PubMed ID: 14872485
    [Abstract] [Full Text] [Related]

  • 16. Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide.
    van der Heijden JW, Oerlemans R, Tak PP, Assaraf YG, Kraan MC, Scheffer GL, van der Laken CJ, Lems WF, Scheper RJ, Dijkmans BA, Jansen G.
    Arthritis Rheum; 2009 Mar 15; 60(3):669-77. PubMed ID: 19248091
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Methotrexate-loaded lipid-core nanocapsules are highly effective in the control of inflammation in synovial cells and a chronic arthritis model.
    Boechat AL, de Oliveira CP, Tarragô AM, da Costa AG, Malheiro A, Guterres SS, Pohlmann AR.
    Int J Nanomedicine; 2015 Mar 15; 10():6603-14. PubMed ID: 26543364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.